Whitehawk Therapeutics Inc (WHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,478 | -11,498 | 5,357 | -3,919 | -23,271 |
| Depreciation Amortization | 9 | 7 | 30 | 15 | 77 |
| Accounts receivable | -13,864 | 54 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,079 | N/A | -239 | N/A | N/A |
| Other Working Capital | -10,506 | 1,256 | 257 | -426 | -1,893 |
| Other Operating Activity | 14,059 | 755 | 946 | 390 | 1,234 |
| Operating Cash Flow | $-12,701 | $-9,426 | $6,352 | $-3,940 | $-23,853 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -12 | N/A | -237 |
| Investing Cash Flow | $N/A | $N/A | $-12 | $N/A | $-237 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,194 | 1,000 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 194 | 0 | 0 | 0 |
| Financing Cash Flow | $1,194 | $1,194 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 15,962 | 15,962 | 38,525 | 38,525 | 62,614 |
| End Cash Position | 4,455 | 7,730 | 44,864 | 34,585 | 38,525 |
| Net Cash Flow | $-11,507 | $-8,232 | $6,340 | $-3,940 | $-24,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,701 | -9,426 | 6,352 | -3,940 | -23,853 |
| Capital Expenditure | N/A | N/A | -12 | N/A | -237 |
| Free Cash Flow | -12,701 | -9,426 | 6,340 | -3,940 | -24,090 |